Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.

× No keyword cloud information.

18 in total

1. Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors: M A Enero; S Z Langer
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1975 Impact factor: 3.000

2. The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Authors: Y Hiroshima; H Miyamoto; F Nakamura; D Masukawa; T Yamamoto; H Muraoka; M Kamiya; N Yamashita; T Suzuki; S Matsuzaki; I Endo; Y Goshima
Journal: Br J Pharmacol Date: 2014-01 Impact factor: 8.739

3. Levodopa reduces risk factors for vascular disease in parkinsonian patients.

Authors: Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti; Massimo Musicco
Journal: J Neurol Date: 2008-05-30 Impact factor: 4.849

4. Long-term depressor effects of noradrenaline and dopamine neurons transplanted into the third ventricle of the brain of salt-loaded hypertensive rats.

Authors: R Hashimoto; F Kimura
Journal: Experientia Date: 1988-06-15

Review 5. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1971 Impact factor: 9.546

6. Action of thymoxamine on mydriasis induced by levodopa and dopamine.

Authors: A S Spiers; D B Calne; S D Vakil; T M French
Journal: Br Med J Date: 1971-05-22

7. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.

Authors: D B Calne; A Petrie; S Rao; J L Reid; S D Vakil
Journal: Br J Pharmacol Date: 1972-01 Impact factor: 8.739

8. Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors: M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal: J Neurol Neurosurg Psychiatry Date: 1973-06 Impact factor: 10.154

9. Bromocriptine in Parkinson's disease: a study of cardiovascular effects.

Authors: N Quinn; A Illas; F Lhermitte; Y Agid
Journal: J Neurol Neurosurg Psychiatry Date: 1981-05 Impact factor: 10.154

10. Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series.

Authors: Kapil D Sethi; Robert A Hauser; Stuart H Isaacson; Terry McClain
Journal: Cases J Date: 2009-07-30